当前位置:首页 - 行情中心 - 山东药玻(600529) - 财务分析 - 现金流量表

山东药玻

(600529)

  

流通市值:123.43亿  总市值:123.43亿
流通股本:6.64亿   总股本:6.64亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,496,355,962.342,402,167,966.031,139,397,765.114,490,886,217.83
  收到的税费返还146,060.71146,060.71140,883.9729,831,962.52
  收到其他与经营活动有关的现金23,184,560.4316,300,369.375,351,512.8734,545,180.3
  经营活动现金流入小计3,519,686,583.482,418,614,396.111,144,890,161.954,555,263,360.65
  购买商品、接受劳务支付的现金1,916,428,388.091,328,682,604.44608,617,445.542,642,662,182.71
  支付给职工以及为职工支付的现金584,831,759.97407,605,746.27222,736,160.18832,623,235.74
  支付的各项税费301,221,598.18221,175,687.4877,251,624.03315,561,608.8
  支付其他与经营活动有关的现金103,775,945.8960,298,287.7623,295,480.98187,491,370.04
  经营活动现金流出小计2,906,257,692.132,017,762,325.95931,900,710.733,978,338,397.29
  经营活动产生的现金流量净额613,428,891.35400,852,070.16212,989,451.22576,924,963.36
二、投资活动产生的现金流量:
  收回投资收到的现金3,990,000,0003,490,000,0002,290,000,0007,990,000,000
  取得投资收益收到的现金15,414,090.4313,021,521.935,914,095.8430,074,799.56
  处置固定资产、无形资产和其他长期资产收回的现金净额6,621,654.885,243,080.7276,2103,197,307.2
  投资活动现金流入小计4,012,035,745.313,508,264,602.652,295,990,305.848,023,272,106.76
  购建固定资产、无形资产和其他长期资产支付的现金325,535,956.85257,408,071.62211,041,960.34231,864,537.19
  投资支付的现金4,020,000,0002,320,000,000820,000,0007,940,000,000
  投资活动现金流出小计4,345,535,956.852,577,408,071.621,031,041,960.348,171,864,537.19
  投资活动产生的现金流量净额-333,500,211.54930,856,531.031,264,948,345.5-148,592,430.43
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金284,258,578.2496,161,963.94-370,341,793.4
  支付其他与筹资活动有关的现金11,172,702.748,181,341.592,079,383.316,408,210.17
  筹资活动现金流出小计295,431,280.98104,343,305.532,079,383.31376,750,003.57
  筹资活动产生的现金流量净额-295,431,280.98-104,343,305.53-2,079,383.31-376,750,003.57
四、汇率变动对现金及现金等价物的影响-16,410,850.24-11,298,295.81-5,991,709.375,793,613.61
五、现金及现金等价物净增加额-31,913,451.411,216,066,999.851,469,866,704.0457,376,142.97
  加:期初现金及现金等价物余额942,557,504.68942,557,504.68942,557,504.68885,181,361.71
  期末现金及现金等价物余额910,644,053.272,158,624,504.532,412,424,208.72942,557,504.68
补充资料:
  净利润-370,867,951.66-689,626,040.66
  资产减值准备-33,853,345.47-156,894,172.13
  固定资产和投资性房地产折旧-185,607,319.86-382,906,229.57
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-185,607,319.86-382,906,229.57
  无形资产摊销-3,424,010.78-6,763,498.71
  处置固定资产、无形资产和其他长期资产的损失--2,495,584.87--1,452,467.75
  固定资产报废损失-3,136,134.53-5,756,957.92
  公允价值变动损失--4,381,715.52--9,136,242.46
  财务费用-11,878,434.33--5,304,673.54
  投资损失--9,582,895.86--17,548,332.44
  递延所得税--1,093,568.64--17,331,349.14
  其中:递延所得税资产减少--1,093,568.64--17,331,349.14
  存货的减少--72,485,409.59--520,117,827.63
  经营性应收项目的减少--46,941,543.83-299,248,910.05
  经营性应付项目的增加--80,718,835.44--390,259,010.65
  其他--441,922.14--4,585,106.93
  不涉及现金收支的投资和筹资活动金额其他项目---43,422,548.42
  现金的期末余额-2,158,624,504.53-942,557,504.68
  减:现金的期初余额-942,557,504.68-885,181,361.71
  现金及现金等价物的净增加额-1,216,066,999.85-57,376,142.97
公告日期2026-10-272026-08-252026-04-252026-03-07
审计意见(境内)标准无保留意见
TOP↑